Windlas Biotech Limited (BOM:543329)
India · Delayed Price · Currency is INR 1,020.70
-14.50 (-1.40%)
At close: Oct 7, 2026
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 21.09 billion as of October 7, 2026. Its market cap has increased by 9.24% in one year.
Market Cap
21.09B
Enterprise Value
18.65B
Revenue
9.42B
Global Rank
n/a
Country Rank
n/a
PE Ratio
31.74
ChartMarket Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 21.09B, an increase of 137.67%. That is a compound annual growth rate of 18.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 21.09B | 26.56% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unichem Laboratories | 38.39B |
| Shukra Pharmaceuticals | 31.86B |
| Hikal | 27.73B |
| Fredun Pharmaceuticals | 24.41B |
| Venus Remedies | 23.78B |
| Syncom Formulations (India) | 23.45B |
| Fermenta Biotech | 16.32B |
| Amrutanjan Health Care | 15.13B |